Latest Zurich Stories
The vaccine based on Cytos' Virus-Like Particle technology may open the door to accelerated production of influenza vaccines in SingaporeSingapore and Schlieren (Zurich), Switzerland, May 17, 2013 - (ACN Newswire) - Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos'...
Switzerland has long been known as a safe place to keep your money. Now it's becoming the ideal location for storing data. Offshore providers like Artmotion are leading the way. SWITZERLAND, May 16, 2013 /PRNewswire-iReach/ -- Switzerland has long been famous for its discreet, trustworthy banks. True, bank secrecy has come under fire around the world in the wake of the global economic crisis - and the Alpine nation has not escaped. However, Swiss banking is unlikely to disappear any...
ZURICH, Switzerland, May 8, 2013 /PRNewswire/ -- Swiss AviationTraining (SAT) unveiled their new CAE Embraer 190 full-flight simulator to the public today. The new facility marks another milestone in SAT's evolution into an experienced provider of total "E-Jet" training solutions, and further underlines its standing and expertise as a competence centre for integrated cockpit, cabin and technical training. SAT's new E-Jet 190 simulator is now available for use at the Lufthansa Flight...
ZURICH, April 30, 2013 /PRNewswire/ -- Dr. Olaf von Maydell has been appointed to the Board of Trustees of the Jacobs Foundation, effective May 1, 2013. A tax consultant who holds a PhD in agricultural economics, Dr. von Maydell is a partner in the Schomerus & Partner tax consulting firm in Berlin. He served as General Manager of the Max Planck Institute for Human Development in Berlin from 2006 to 2011, and from 2001 to 2006 he was Head of Finance for Doctors Without...
Client Demand Prompts Vaulting Expansion in Singapore NEW YORK, April 30, 2013 /PRNewswire/ -- Gold Bullion International (GBI), a leading provider of physical precious metals to the wealth management industry, today announced an expansion of its silver offering to include overseas storage in Singapore, facilitated by their vaulting network. Of the company's additional vaulting locations in New York, Salt Lake City, Zurich, London, and Melbourne, the Singapore vault is the latest...
ZURICH, April 25, 2013 /PRNewswire/ -- - Phase 2b clinical trial of CYT003 in allergic asthma on-going as planned - Cytos' VLP platform is basis for a phase 1 clinical trial with an Anti-lgE Vaccine partnered with and conducted by Pfizer - Management team further strengthened - The Journal of Allergy and Clinical Immunology publishes phase 2a...
ZURICH, April 19, 2013 /PRNewswire/ -- 2013 Ranking of the Strongest Social Network Brands The department of Social Media Management of HWZ University of Applied Sciences in Business Administration Zurich, in cooperation with BV4 Certified Brand Valuation Experts, present the 2013 ranking of the most valuable social media brands. The four most valuable brands in 2012 were able to defend their leading positions and increase their brand values: Facebook takes the top of...
ETH Life Inspired by plant components that respond to external stimuli, material scientists from ETH Zurich have devised a new method for producing composite materials from a variety of materials that adopt a pre-programmed shape autonomously. Plant components that bend, roll or twist in response to external stimuli such as temperature or moisture are fairly commonplace in nature and often play a role in the dispersal of seeds. Pine cones, for instance, close their scales when wet and...
ZURICH, Switzerland, March 21, 2013 /PRNewswire/ -- Demonstrates Takeda's long-term commitment to the Latin American market Takeda Pharmaceuticals International GmbH ("Takeda"), today announced further expansion of its presence in Latin America with the launch of its wholly-owned subsidiary in Ecuador. Takeda Ecuador S.A. (Takeda Ecuador or "the Company") will be headquartered in Quito and will be responsible for the sales and marketing of Takeda's products in Ecuador....
ZURICH, March 13, 2013 /PRNewswire/ -- Cytos Biotechnology Ltd (SIX:CYTN) today announced the publication of the results from its phase 2a clinical trial with CYT003-QbG10 (CYT003), a first-in-class immune modulator in clinical development as a potential new treatment for allergic asthma. The data are published in the March issue of The Journal of Allergy and Clinical Immunology (JACI) in the article entitled "The novel TLR-9 agonist QbG10 shows clinical efficacy in...
